Kolon TissueGene, Inc. (KOSDAQ:950160)

Kolon TissueGene Ratios and Metrics

Market cap in millions KRW. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Oct 9, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	3,735,488	1,847,594	655,804	612,433	518,608	489,552
Market Cap Growth	229.64%	181.73%	7.08%	18.09%	5.93%	-
Enterprise Value	3,754,012	1,835,745	610,221	540,002	508,454	433,489
Last Close Price	45000.00	23250.00	9020.00	8890.00	8010.00	8010.00
PS Ratio	680.10	364.17	176.95	64.77	129.55	137.68
PB Ratio	32.22	12.66	5.70	6.69	13.42	10.18
P/TBV Ratio	32.26	12.68	5.71	6.71	13.49	10.24
EV/Sales Ratio	-	361.84	164.66	57.11	127.01	121.91
Debt / Equity Ratio	0.39	0.12	0.06	0.08	0.19	0.32
Asset Turnover	0.02	0.03	0.03	0.11	0.06	0.04
Inventory Turnover	51.76	57.42	82.64	19.35	14.10	7.63
Quick Ratio	0.17	0.02	2.01	5.08	2.44	3.76
Current Ratio	0.21	0.10	2.24	5.44	2.69	4.15
Return on Equity (ROE)	-63.01%	-25.91%	-16.69%	-17.11%	-109.20%	-59.58%
Return on Assets (ROA)	-6.27%	-7.70%	-10.47%	-11.90%	-43.86%	-26.38%
Return on Capital (ROIC)	-8.77%	-9.66%	-11.65%	-14.11%	-53.78%	-29.09%
Earnings Yield	-2.35%	-1.83%	-2.63%	-1.82%	-9.13%	-8.54%
FCF Yield	-0.65%	-1.11%	-3.72%	-4.38%	-7.82%	-7.96%
Buyback Yield / Dilution	-7.73%	-7.32%	-8.18%	-8.25%	-0.29%	0.06%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.